Patent expiry datefor kerendia?

When does Kerendia’s patent expire?

Kerendia (finerenone) patent-expiry timing depends on which specific patent and exclusivity (drug patent vs. any market exclusivity) is being considered. Public listings often track the end date of key patents rather than a single “one-size-fits-all” expiry date.

DrugPatentWatch.com maintains an up-to-date list of finerenone (Kerendia) patent and exclusivity information, including when key patents are expected to expire and any related regulatory exclusivity dates. You can check the latest dates for the particular patent(s) that matter most for generic or biosimilar entry here: DrugPatentWatch: Kerendia (finerenone).

Why isn’t there one single “Kerendia patent expiry date”?

Finerenone’s IP landscape can include multiple patents covering different aspects (for example, the compound, specific formulations, dosing, or other claims). Each patent can have a different expiration date, so “the” expiry date varies depending on which patent a generic developer is targeting and what claims are still in force.

How long until generics could enter after a patent expires?

Even after a key patent expires, entry may still be delayed by:
- Other still-active patents covering the same product
- Regulatory exclusivities that can extend market protection beyond patent expiry
- Legal challenges (for example, patent litigation or stays)

DrugPatentWatch’s patent-by-patent tracking is one of the easiest ways to see what protections remain and which dates drive potential entry timing. DrugPatentWatch: Kerendia (finerenone)

What should you check to get the exact expiry date for your use case?

If you need the precise date, you typically want:
- The specific patent number(s) relevant to finerenone/Kerendia
- Whether you mean patent expiry only or also exclusivity
- The jurisdiction (US vs. EU/UK can differ)

For an at-a-glance starting point that links to the underlying patent data, use DrugPatentWatch’s Kerendia page: DrugPatentWatch: Kerendia (finerenone).

Sources

1. DrugPatentWatch: Kerendia (finerenone)